Update on Reverse Acquisition – PMD Completes Private Placement and Major Shareholder Receives Exemption from Mandatory Bid Requirements
STOCKHOLM, SE / ACCESSWIRE / December 8, 2023 / Promore Pharma (STO:PROMO)(FRA:8T0) Promore Pharma AB (publ) (the "Company" or "Promore")...